Abstract
Purpose: To determine current practice in the prevention and management of corneal allograft rejection in Australia. Methods: A questionnaire was circulated to attendees at the 1998 Eye Bank Meeting in Adelaide. Twenty-four responses were received and analysed. Results: All respondents used topical corticosteroids for routine prophylaxis and to treat established rejection episodes. Prednisolone acetate was the most frequently prescribed topical corticosteroid. Systemic non-steroidal immunosuppression was prescribed almost exclusively for high-risk grafts. Seventy-five per cent of surgeons used systemic antiviral agents for the treatment of graft rejection in patients with Herpes simplex keratitis. Conclusion: There was a wide variation amongst surgeons in the choice of therapy for routine prophylactic immuno-suppression as well as for the treatment of established corneal allograft rejection.
Original language | English |
---|---|
Pages (from-to) | 357-360 |
Number of pages | 4 |
Journal | Clinical and Experimental Ophthalmology |
Volume | 28 |
Issue number | 5 |
DOIs | |
Publication status | Published - Oct 2000 |
Keywords
- Antiviral agents
- Corneal graft rejection
- Corticosteroids
- Immunosuppression
- Penetrating keratoplasty